Plasma concentrations of IGF-1 and the ratio of IGF-1/IGFBP-3 have been under clinical evaluation for their association with vascular diseases, i.e., age related cognitive status and stroke recovery [1,96,110]. Here, IGF1 is linked to stroke disorder.